PDB ID: 3SW2
Hetero Atom Contents
The number of atoms exceeds 100,000. So, it can not be displayed here.
Select unit:
Select hetatm:
Select chain: Sequence
Data format:
Color scheme of protein:
| Code | Name | Style | Show | Link | |
|---|---|---|---|---|---|
| CA | Calcium ion | PoSSuM | |||
| FI1 | 6-chloro-N-((3s)-2-oxo-1-(2-oxo-2-((5s)-8-oxo-5,6-dihydro-1h-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2h,4h,8h)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide | PoSSuM | |||
| GOL | Glycerol | PoSSuM | |||
| NA | Sodium ion | PoSSuM |
| Code | Name | Show |
|---|
| Code | Name | Emphasize |
|---|
| Code | Name | Show |
|---|
Download interaction data: 3SW2
Structure summary
| Code : | 3SW2 PDBj RCSB PDB PDBe | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Header : | HYDROLASE/HYDROLASE INHIBITOR | ||||||||||||||||||||||||
| Title : | X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-5,6-dihydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2H,4H,8H)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide | ||||||||||||||||||||||||
| Release Data : | 2011-11-16 | ||||||||||||||||||||||||
| Compound : |
|
||||||||||||||||||||||||
| Source : |
|
||||||||||||||||||||||||
| Authors : | Klei, H.E. | ||||||||||||||||||||||||
| Keywords : | serine protease, epidermal growth factor-like domain, blood coagulation factor, cleavage on pair of basic residues, EGF-like domain, gamma-carboxyglutamic acid, glycoprotein, hydroxylation, zymogen, HYDROLASE, BLOOD CLOTTING, HYDROLASE-HYDROLASE INHIBITOR complex | ||||||||||||||||||||||||
| Exp. method : | X-RAY DIFFRACTION ( 2.420 Å ) | ||||||||||||||||||||||||
| Citation : |
Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.
Shi, Y.,O'Connor, S.P.,Sitkoff, D.
et al.
PubMed: 22041058 |
||||||||||||||||||||||||
Reaction
| Chain : | B | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| UniProt : | P00742 (FA10_HUMAN) | ||||||||
|
|||||||||


